- Home
- BDTX vs SOPH Comparison
BDTX vs SOPH Comparison
Compare BDTX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- SOPH
- Stock Information
- Founded
- BDTX 2014
- SOPH 2011
- Country
- BDTX United States
- SOPH Switzerland
- Employees
- BDTX N/A
- SOPH N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BDTX Health Care
- SOPH Health Care
- Exchange
- BDTX Nasdaq
- SOPH Nasdaq
- Market Cap
- BDTX 181.4M
- SOPH 231.8M
- IPO Year
- BDTX 2020
- SOPH 2021
- Fundamental
- Price
- BDTX $3.23
- SOPH $3.32
- Analyst Decision
- BDTX Strong Buy
- SOPH
- Analyst Count
- BDTX 6
- SOPH 0
- Target Price
- BDTX $12.50
- SOPH N/A
- AVG Volume (30 Days)
- BDTX 836.3K
- SOPH 38.2K
- Earning Date
- BDTX 11-04-2025
- SOPH 11-04-2025
- Dividend Yield
- BDTX N/A
- SOPH N/A
- EPS Growth
- BDTX N/A
- SOPH N/A
- EPS
- BDTX 0.25
- SOPH N/A
- Revenue
- BDTX $70,000,000.00
- SOPH $69,688,000.00
- Revenue This Year
- BDTX N/A
- SOPH $16.60
- Revenue Next Year
- BDTX N/A
- SOPH $18.77
- P/E Ratio
- BDTX $12.66
- SOPH N/A
- Revenue Growth
- BDTX N/A
- SOPH 7.32
- 52 Week Low
- BDTX $1.20
- SOPH $2.58
- 52 Week High
- BDTX $6.23
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- BDTX 55.11
- SOPH 50.54
- Support Level
- BDTX $2.56
- SOPH $3.10
- Resistance Level
- BDTX $3.43
- SOPH $3.49
- Average True Range (ATR)
- BDTX 0.15
- SOPH 0.16
- MACD
- BDTX -0.15
- SOPH -0.01
- Stochastic Oscillator
- BDTX 94.61
- SOPH 53.66
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.